Abstract The aim of this study was to estimate the hospitalization incidence and the total number of hospital days related to all fractures and osteoporotic fractures in the year 2000 in Switzerland and to compare these with data from other frequent disorders in men and women. The official administrative and medical statistics database of the Swiss Federal Office of Statistics (SFOS) from the year 2000 was used. It covered 81.2% of all registered patient admissions and was considered to be representative of the entire population. We included the ICD-10 codes of 84 diagnoses that were compatible with an underlying osteoporosis and applied the best matching age-specific osteoporosis attribution rates published for the ICD-9 diagnosis codes to the individual ICD-10 codes. To preserve comparability with previously published data from 1992, we grouped the data related to the ICD-10 fracture codes into seven diagnosis pools (fractures of the axial skeleton, fractures of the proximal upper limbs, fractures of the distal upper limbs, fractures of the proximal lower limbs, fractures of the distal lower limbs, multiple fractures, and osteoporosis) and analyzed them separately for women and men by age group. Incidences of hospitalization due to fractures were calculated, and the direct medical costs related to hospitalization were estimated. In addition, we compared the results with those from chronic pulmonary obstructive disease (COPD), stroke, acute myocardial infarction, heart failure, diabetes and breast carcinoma from the same database. In Switzerland during 2000, 62,535 hospitalizations for fractures (35,586 women and 26,949 men) were registered. Fifty-one percent of all fractures in women and 24% in men were considered as osteoporotic. The overall incidences of hospitalization due to fractures were 969 and 768 per 100,000 in women and men, respectively. The hospitalization incidences for fractures of the proximal lower limbs and the axial skeleton increased exponentially after the age of 65 years. The direct medical cost of hospitalization of patients with osteoporosis and/or related fractures was 357 million CHF. Hip fractures accounted for approximately half of these costs in women and men. Among other common diseases in women and men, osteoporosis ranked number 1 in women and number 2 (behind COPD) in men. When compared with data from 1992, the average length of stay had shortened by 8.4 days for women and 4.7 days for men, leading to a decrease of almost 40% in direct medical costs related to acute hospitalizations. This apparent decrease in cost might result from a shift into the ambulatory cost segment, for which the assessment and management tools need to be developed. We conclude that, in 2000, osteoporosis continued to be a heavy burden on the Swiss healthcare system. Lack of awareness of the disease and its consequences prevents widespread use of drugs with antifracture efficacy. This limits their potential to reduce costs.
and ankle [1, 3, 4, 5, 6] . In osteoporotic patients virtually any bone may be fractured by so-called inadequate or low-energy trauma.
In 1992 we estimated the annual direct medical costs of hospitalization due to osteoporotic fractures in Switzerland that had been recorded by the medical statistics department of VESKA (Vereinigung Schweizerischer Krankenhaeuser, the Swiss Hospital Association), and compared these costs with those due to other common diseases in men and women. We concluded that osteoporotic fractures in women consumed more healthcare resources than chronic pulmonary obstructive disease (COPD), stroke, breast carcinoma and myocardial infarction (MI). In men, osteoporosis ranked fourth behind COPD, MI and stroke [7] .
The aim of our study was to update our knowledge of the socio-economic burden of osteoporosis in Switzerland by analyzing the hospitalization incidence and the total number of hospitalization days related to osteoporotic fractures, and fractures in general, and to compare the total hospitalization days due to osteoporosis with those caused by other common disorders in men and women.
Materials and methods

Source of hospital statistics
The administrative and medical statistics database of the Swiss Federal Office of Statistics (SFOS) from 2000 was used. Since 1998 all Swiss acute hospitals, as well as rehabilitation centers and specialized clinics, have been obliged to supply data to the SFOS. There were 376 such institutions, and administrative statistics were available from 372 of them (four had closed during 2000). These administrative statistics consolidate the data relating to finance, human resources, numbers of beds and patient admissions. Medical statistics were available from 343 hospitals (91.2%), corresponding to 81.2% of all registered patient admissions. We used those medical statistics to determine the number of hospitalized fractures and to calculate the mean length of stay (LOS) by fracture type, age group and gender. All data were extrapolated to 100% to become representative for Switzerland as a whole.
Definition of fracture and osteoporotic fracture
In the medical statistics database the diagnoses were coded as main or secondary. To calculate the numbers of diagnoses related to fractures and/or osteoporosis, we retained both main and secondary diagnoses. All diagnoses were coded according to the ICD-10 classification. Eighty-four ICD-10 codes were relevant to our analysis, and they were assigned to four categories: -Category 1: osteoporosis coded as such. There were 21 relevant ICD-10 codes; osteoporosis without pathologic fracture: M81.0 (postmenopausal osteoporosis), M81.1 (osteoporosis after ovariectomy), M81.2 (immobilization osteoporosis), M81.3 (osteoporosis consecutive to post-surgical malabsorption), M81.4 (drug-induced osteoporosis), M81.5 (idiopathic osteoporosis), M81.6 (regional osteoporosis [Lequesne]), M81.8 (other osteoporosis), M81.9 (osteoporosis, no further mention), M82.0 (osteoporosis with plasmacytoma), M82.1 (osteoporosis with endocrine diseases), M82.8 (osteoporosis with other classified diseases); osteoporosis with pathologic fracture: M80.0 (postmenopausal osteoporosis with pathologic fracture), M80.1 (osteoporosis with pathologic fracture after ovariectomy), M80.2 (immobilization osteoporosis with pathologic fracture), M80.3 (osteoporosis consecutive to postsurgical malabsorption with pathologic fracture), M80.4 (drug-induced osteoporosis with pathologic fracture), M80.5 (idiopathic osteoporosis with pathologic fracture), M80.8 (other osteoporosis with pathologic fracture), M80.9 (osteoporosis, no further mention with pathologic fracture), M84.4 (pathologic fracture, not classified elsewhere).
-Category 2: osteoporosis-related clinical entities not defined as osteoporosis, including back pain and kyphosis. Comprises six relevant ICD-10 codes (Table 1 ).
-Category 3: fractures possibly due to osteoporosis, typically those caused by low-energy trauma. Comprises 28 eligible ICD-10 codes (Table 2 ).
-Category 4: fractures unlikely to be due to osteoporosis, typically those caused by high-energy trauma. Comprises 29 relevant ICD-10 codes: S42.0 (fracture clavicula), S42.4 (fracture humerus distal), S42.7 (multiple fractures clavicula), S42.8 (other 
Osteoporosis attribution rates
The percentage of hospitalization cases related to osteoporosis was estimated by applying the best matching age-specific attribution rates published for the ICD-9 diagnosis codes [7, 8, 9 ] to the individual ICD-10 codes.
To preserve comparability with our previous publication, we used the conservative attribution rates published by Phillips et al. [8] , although a more recent and detailed publication from Melton et al. examines agespecific and gender-specific attribution rates and indicates that osteoporosis might be the underlying cause of fracture more frequently than initially suspected [9] . In category 1 all recorded cases were counted as being due to osteoporosis (attribution rate 100%). In category 2 all cases were weighted according to the age-specific attribution rates (Table 1 ). In category 3 (main diagnosis fracture), cases with a secondary diagnosis of osteoporosis were attributed to osteoporosis (attribution rate 100%) and cases with a secondary diagnosis other than osteoporosis were weighted according to the agespecific attribution rates ( Table 2 ). In category 4 (main diagnosis fracture), cases with a secondary diagnosis of osteoporosis were attributed to osteoporosis (attribution rate 100%), while cases with a secondary diagnosis other than osteoporosis were considered as not being due to osteoporosis (attribution rate 0%).
Data pooling for analysis
In a second step, to preserve comparability with previously published data [7] , we grouped the ICD-10 frac- ture codes into seven diagnosis pools and tabulated them separately for women (Table 3 ) and men ( Estimation of the direct medical costs related to hospitalization
The Administrative Statistics showed the operational cost for general hospitals (including university hospitals) as being CHF 1,009 per hospital day and CHF 703 as the weighted average cost per day in special or rehabilitation clinics. It was assumed that within a given age group the mean length of stay was the same whether osteoporosis was the underlying cause or not. We multiplied the number of hospital days by the number of cases and by the cost per day to obtain an estimation of the total hospitalization costs related to osteoporosis and its complications.
Selected diseases used as comparators
Hospitalization days caused by COPD (ICD-10 codes J40-J47), stroke (I64, I66), acute myocardial infarction (I21, I22), heart failure (I50), diabetes (E10-E14) and breast carcinoma (C50) were assessed by the same methodology as described above. Those diseases represent well-established nosologic entities and are usually coded as the main diagnosis if they are the main reason for hospitalization. In contrast to osteoporosis, where fractures can be attributed to the underlying disease with a given probability, no such attribution rates exist for the complications of the selected comparator diseases. Therefore, we focused on the main diagnosis only.
Results
Hospitalizations due to fractures and osteoporotic fractures
In Switzerland 62,535 hospitalizations for fractures (35,586 women and 26,949 men) occurred during 2000 (Tables 3 and 4) . Overall, 51% of those hospitalizations in women and 24% in men were considered to be due to osteoporosis, with large differences according to fracture site and gender. Thus, 80% of the hospitalizations for fractures of the proximal lower limbs and 59.3% of those for fractures of the axial skeleton were considered as osteoporotic in women (56.5% and 37.5%, respectively, in men), whereas 41% of the hospitalizations for distal upper limb fractures and 20% of those for distal lower limb fractures were considered as osteoporotic in women (8.9% and 13.1%, respectively, in men). In women, osteoporosis coded as such (ICD-10 M81 and M82) accounted for 3.5% (compared to 1.6% in men) of the total hospitalized cases attributable to osteoporosis based on the attribution rates.
Incidences of hospitalizations due to fractures
The incidences of hospitalization due to fractures were 969 and 768 per 100,000 in women (Table 3 ) and men (Table 4) , respectively. Pooled incidences by fracture site and age group are shown for women and men in Figs. 1 and 2, respectively. The incidence of hospitalization for fractures of the proximal lower limbs and the axial skeleton sharply increased after the age of 65 years in both genders. The incidence of fractures of the proximal lower limbs was higher in men than in women up to the age of 54 years, and similar at 45-54 years (108/100,000 and 111/100,000, respectively) and rose exponentially thereafter in both genders. At age 85+ the incidence was 3,874/100,000 in women and 1,940/100,000 in men. The incidence of hospitalization for fractures of the axial skeleton also increased strongly with age, from 68/ 100,000 (0-44 years) to 1,690/100,000 (85+ years) in women, and from 97/100,000 to 784/100,000 in men in the same age groups.
Direct medical costs related to hospitalization
The total estimated cost due to osteoporosis and related fractures in Switzerland in 2000 was 357 million CHF. In women, a total of 35,586 hospitalizations, amounting to 503,319 hospital days, were estimated to be due to fractures in 2000. The mean length of stay was 14.1 days. The total hospital costs were approximately 473 million CHF, corresponding to a mean cost per case of 13,312 CHF. In all, 18,037 hospitalizations have been estimated to be due to osteoporotic fractures and accounted for a total of 286,397 hospital days, with a mean length of stay of 15.9 days. The total hospital cost was estimated at 263.6 million CHF, corresponding to a mean cost per case of 14,616 CHF. The hip fracture group had the largest number of cases and the longest length of stay (19.1 days, on average) and accounted for more than 50% of the estimated total hospitalization costs for osteoporotic fractures. Fractures of the axial skeleton accounted for 30% of these costs (Table 3) .
In men, the number of hospitalizations due to fractures in general was 26'949 in 2000, with a mean length 12,678 S13 of stay of 10.1 days, i.e., 4.0 days fewer or 28% less than in women. These cases accounted for 272,625 hospital days, i.e., almost 50% less than in women. The cost of hospitalizations was estimated at 259.2 million CHF, corresponding to a mean cost per case of 9,620 CHF. Twenty-four percent of all hospitalizations for fractures were considered as related to osteoporosis, with 87,100 hospital days and 13.5 days average length of stay (LOS). The estimated cost of hospitalization due to osteoporotic fractures was 82 million CHF, with a mean cost per case of 12,674 CHF. As in women, the main cost drivers were hip fractures. They were more frequent and produced the longest LOS (17.9 days), accounting for 47% of the estimated total hospitalization costs for osteoporotic fractures. Fractures of the axial skeleton accounted for 33% of these costs (Table 4) .
Comparison with other frequent diseases
In women the age-independent incidence of hospitalization for osteoporosis or its complications was twice as high as that for breast cancer and pooled cardiovascular diseases (heart failure and myocardial infarction and stroke), almost three-times as high as that for COPD and six-times higher than that for diabetes (Fig. 3) . The mean LOS for osteoporosis was similar to that of all the other diseases included in the analysis, with the exception of stroke (twice as long) and breast cancer (50% shorter) (Fig. 4) . Osteoporosis accounted for 1.5-times more hospital days than pooled cardiovascular diseases, two-to-three-times more than COPD or breast cancer and six-times more than diabetes (Fig. 5) .
In men the disease with the highest hospitalization incidence and the highest number of hospital days was COPD. The overall incidence of hospitalizations for osteoporosis was identical to the incidence of hospitalizations for myocardial infarction, with a longer mean length of stay and almost 50% more hospital days (Figs. 6, 7 and 8 ).
Discussion
In a previous study [7] , which used similar methods to analyze the 1992 statistics database of the VESKA (Vereinigung Schweizer Krankenha¨user, Federation of Swiss Hospitals), we assessed the incidence rate of fractures and estimated the direct medical costs linked to hospitalizations for osteoporosis and its complications.
The 1992 data showed a total of 63,170 hospitalizations for fractures (53% in women) and the annual incidences of hospitalizations for fractures were 950 per 100,000 and 877 per 100,000 in women and men, respectively. In 2000 these values were very similar: 62,535 hospitalizations for fractures, 57% in women, and incidences of 969 per 100,000 and 768 per 100,000 in women and men, respectively. In 1992 the total number of hospitalized osteoporotic fractures was 18,380 in women (vs 18,037 in 2000) and 7,619 in men (vs 6,470 in 2000). Between 1992 and 2000 the average length of stay shortened considerably, from 24.3 days to 15.9 days ()8.4 days) in the case of women and from 18.2 to 13.5 days ()4.7 days) in the case of men. This led to a decrease of almost 40% in direct medical costs related to acute hospitalizations for osteoporosis.
As compared to 1992, the number of osteoporotic fractures of the proximal lower limbs (mainly hip fractures) increased by almost 10% in women and 21% in men. In women the number of hospitalizations due to fractures of the axial skeleton increased by 25%. For all other fracture sites the number of hospitalizations decreased by up to 35% (Table 5 ). The lengths of stay decreased markedly for all fracture types, the largest change being seen for hip fractures (around 50%) and the least change for fractures of the axial skeleton (around 25%), (Table 6 ). In women in 1992 osteoporosis was the leading disease, followed by COPD, stroke, breast cancer and myocardial infarction. This ranking, and the respective orders of magnitude, remained similar in 2000. In men in 1992 COPD was the leading cause of hospitalization, followed by myocardial infarction, stroke and osteoporosis. In 2000, in men, osteoporosis progressed from rank 4 to rank 2, ahead of stroke and myocardial infarction.
There are several possible explanations for these observations. The Swiss statistical data collection system has recently changed: in 1992 the VESKA statistics were derived from a representative sample of 43% of the Swiss hospitals, based on voluntary membership, which we extrapolated to 100%. In 2000, membership of the SFOS was mandatory, and the data shown here were extrapolated from a statistics database representing 81.2% of all hospital admissions. The differences in source data and in the extrapolated sample size might have introduced some variance. However, as the 1992 VESKA data were a representative sample for all Swiss hospitals, and as a greater percentage of hospitals reported data in 2000, the data shown here can be considered a realistic scenario of the number of fractures and hospitalizations in Switzerland in both years. The ICD coding system was changed from ICD-9 in 1992 to the more detailed ICD-10 in 2000. However, the ICD-10 contains codes similar to those in ICD-9, and the data pooling was done on the basis of diagnoses compatible with the ICD-9 data classification of 1992. In addition, the incidence of hip fractures, which almost always cause hospitalization, increased between 1992 and 2000, which is in line with long-term projections for several countries: an increase of 38% in hip fracture incidence between 1983 and 2010 was projected for Finland [10] and 45% between 1986 and 2020 in the USA [11] . Some scenarios even show an increase in the age-specific fracture risk, i.e., an increase in the osteoporosis attribution rate for hip fractures [12, 13] . This has led to a prediction of a 150% increase in hip fracture rate in the UK between 1985 and 2016 [14] . For Switzerland, based on the population ageing scenarios predicted by the SFOS, and assuming that the osteoporosis attribution rate by age group would remain constant, we estimated that an increase in the annual incidence of hip fracture cases, by 55% between 1992 and 2020, could be realistically expected [15] .
The large decrease in the mean length of stay observed for all fractures may have several explanations. Cost containment measures have affected the Swiss healthcare system increasingly over the past 10 years, leading to cost savings at the hospital level. These savings have been brought about by a shift from hospitalization to ambulatory treatment and by earlier hospital discharge as a result of improved orthopedic surgical techniques and the shift to ambulatory post-surgery follow-up. A similar decrease in length of stay has been observed with all the other common diseases used as comparators. In women the average LOS for breast cancer hospitalizations was reduced from 25.7 days in 1992 to 10.5 days in 2000. A similar reduction was observed for heart failure (from 27.1 to 16.8 days), diabetes (from 25.2 to 15.9 days), myocardial infarction (from 16.7 to 13.5 days), stroke (from 39.9 to 33.1 days) and COPD (from 20.1 to 17.8 days). In men the average LOS was reduced for all the diseases, with the exception of stroke, used as comparators (myocardial infarction decreased from 14.1 to 9.3 days, heart failure from 18.1 to 14.8 days, diabetes from 19.5 to 17.2 days, COPD from 17.7 to 16.7 days; stroke increased from 30.0 to 33.5 days).
It is, therefore, likely that a major part of the direct medical costs of osteoporosis have moved from the well- Since 1996, drugs with a proven effect on the individual fracture risk at all clinically relevant sites, such as the bisphosphonates alendronate and risedronate, have been available to Swiss physicians. Although these drugs prevent hip fractures (significant reduction of fracture risk up to 50% in well-designed fracture endpoint trials, with a measurable between-groups difference after 36 months [16, 17, 18, 19] ), and although the efficacy of vitamin D substitution and nutritional measures in institutionalized elderly people is well documented [20, 21, 22] , there has been an increase in hospitalizations for hip fractures over the past 8 years. Projections from bisphosphonate sales data (IHA/IMS Health, Hergiswil, 2003) for 2000 suggest that fewer than 10% of Swiss women with osteoporosis were being treated with these drugs. The year 2000 fracture and hospitalization data might, therefore, fail to detect a treatment effect on fracture risk. According to the same source, the availability of the new once-weekly formulations would broaden the use of these drugs to approximately 20% of all women with osteoporosis by the end of 2003, making it more likely that we will observe a population effect in the future. However, the awareness of osteoporosis remains low in Switzerland. In the present analysis, and in the 9,126 reported cases of femoral fracture, only 346 (5.4%) mentioned osteoporosis as a secondary diagnosis in women. This value drops to 1.9% in men.
Osteoporosis and its complications were the leading drivers of direct medical costs related to hospitalization in women in 2000 in Switzerland and were comparable, as cost drivers, to myocardial infarction in men. Although progress has been made in shortening acute hospitalization stays and ambulatory treatment of fractures, the costs related to osteoporosis have been shifted into the ambulatory cost segment, for which the assessment and management tools remain underdeveloped. Awareness of the consequences of the disease remains low. This prevents the widespread use of drugs that decrease fracture risk in osteoporotic patients and, thereby, limits their potential contribution to cost containment.
